Read more
Informationen zum Autor William G. Kerr, Empire Scholar and Murphy Family Professor of Children's Oncology, Pediatrics and Micriobiology & Immunology, SUNY Upstate Medical University. Klappentext "A recent upsurge of research examining inositol phospholipids (IP)--membrane-bound species fundamental to cell signalincontinues underscore the role of this pathway in both normal and disease-associated cellular physiology. This volume includes a selection of cutting-edge, multidisciplinary reports borne out of the conference "Inositol Phospholipid Signaling in Physiology and Disease" held June 26-27, 2012 at the New York Academy of Sciences in New York City. Papers include important developments investigating IP signaling in immunology, cancer, inflammation, and metabolic disorders"--Publisher's description. Zusammenfassung A recent upsurge of research examining inositol phospholipids (IP) membrane-bound species fundamental to cell signaling continues underscore the role of this pathway in both normal and disease-associated cellular physiology. Inhaltsverzeichnis Introduction to Inositol Phospholipid Signaling in Physiology and Disease v William G. Kerr and Sandra Fernandes Phosphoinositide 3-kinase and INPP4B in human breast cancer 1 Micka C. Bertucci and Christina A. Mitchell Role of SHIP1 in cancer and mucosal inflammation 6 Sandra Fernandes, Sonia Iyer, and William G. Kerr Role of SHIP1 in bone biology 11 Sonia Iyer, Bryan S. Margulies, and William G. Kerr Achieving cancer cell death with PI3K/mTOR-targeted therapies 15 Sung Su Yea and David A. Fruman Challenges in the clinical development of PI3K inhibitors 19 Cristian Massacesi, Emmanuelle di Tomaso, Nathalie Fretault, and Samit Hirawat Rules of engagement: distinct functions for the four class I PI3K catalytic isoforms in immunity 24 Klaus Okkenhaug Control of T cell tolerance by phosphatase and tensin homolog 27 Alexandria Huynh and Laurence A. Turka Role of PI3K/Akt and mTOR complexes in Th17 cell differentiation 30 Shigenori Nagai, Yutaka Kurebayashi, and Shigeo Koyasu Targeting phosphoinositide 3-kinase ¿ for the treatment of respiratory diseases 35 Srividya Sriskantharajah, Nicole Hamblin, Sally Worsley, Andrew R. Calver, Edith M. Hessel, and Augustin Amour Phosphoinositide 3-kinase gamma in T cell biology and disease therapy 40 Wai-Ping Fung-Leung Inhibition of phosphoinositide 3-kinase ¿ attenuates inflammation, obesity, and cardiovascular risk factors 44 Matthias P. Wymann and Giovanni Solinas Class III PI3K Vps34: essential roles in autophagy, endocytosis, and heart and liver function 48 Nadia Jaber and Wei-Xing Zong Inpp4b is a novel negative modulator of osteoclast differentiation and a prognostic locus for human osteoporosis 52 Jean Vacher ...
